Wang et al. in 2012 demonstrated in HCC that HDAC1 and HDAC3 act as negative regulators of miR-224 expression, whereas the histone acetyl-transferase EP300 is a positive regulator. The gene discussed is EP300; the disease is hepatocellular carcinoma.